TIPPS: Thrombophilia in Pregnancy Prophylaxis Study

Completed · Phase 3

Conditions studied: Pregnancy, Thrombophilia, Pregnancy Complications

In brief

The TIPPS trial seeks to determine the safety and effectiveness of low-molecular-weight heparin (LMWH), an anticoagulant, in preventing placenta mediated pregnancy complications and venous thromboembolism (VTE) in women with thrombophilia. Thus, the principal research question is: can LMWH prevent thrombosis in the leg veins, pulmonary arteries and placental vessels, thereby reducing the risk of deep vein thrombosis, pulmonary embolism (PE), intrauterine growth restriction (IUGR), preeclampsia, miscarriage and stillbirth?

Key facts

Study ID

NCT00967382

Run by

Ottawa Hospital Research Institute

People needed

292

Starts

2000-07-01

Expected to finish

2014-03-01

Last updated by the study team

2014-05-19

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• One or more of the following:
• Previous preeclampsia
• Previous unexplained intra-uterine growth restriction
• Previous recurrent miscarriage:
• three(3) or more unexplained miscarriage at less than 10 weeks gestation;
• two (2) or more unexplained fetal loss between 10 and 16 weeks gestation;
• one (1) or more unexplained fetal loss at or greater than 16 weeks gestation
• Previous abruptio placenta
• Previous personal history of VTE:
• Previous documented secondary proximal VTE,
• Previous documented calf-vein thrombosis (idiopathic or secondary),
• Previous superficial phlebitis
• First degree relative with symptomatic thrombophilia
• Pregnancy - > 4weeks gestation and < 20 weeks gestation
• Thrombophilia:
• Two abnormal tests, and no normal tests
• 3.1 Protein S
• 3.2 Protein C
• 3.3 Antithrombin
• Two positive tests
• 3.4 Anticardiolipin immunoglobulin M (IgM) (>30 U/ml)
• 3.5 Anticardiolipin immunoglobulin G (IgG) (>30 U/ml)
• 3.6 Anti-b2 glycoprotein IgG (>20 U/ml)
• 3.7 Anti-b2 glycoprotein IgM (>20 U/ml)
• 3.8 Lupus anticoagulant

You may not qualify if…

• Less than 4 weeks gestation or greater than 20 weeks gestation
• No confirmed thrombophilia
• Contraindication to heparin therapy
• History of heparin induced thrombocytopenia
• Platelet count less than 100,000 109/L
• History of osteoporosis or steroid use
• Actively bleeding
• Documented peptic ulcer within 6 weeks
• Heparin, bisulfite or fish allergy
• Severe hypertension (Systolic Blood Pressure >200mmhg and/or Diastolic Blood Pressure >120mmHg)
• Serum creatinine greater than 80 umol/L (1.3mg/dl) and an abnormal 24 hour urine creatine clearance (<30ml/min)
• Severe hepatic failure (INR >1.8)
• Geographic inaccessibility
• Need for anticoagulants, discretion of the investigator such as but not limited to:
• Recurrent fetal loss and phospholipid antibody syndrome
• Prior idiopathic proximal VTE:
• History of idiopathic deep venous thrombosis (DVT) or pulmonary embolism (PE) treated with anticoagulants (> 1 month of heparin or warfarin) or inferior vena cava (IVC) interruption;
• Idiopathic is a VTE occurring outside all of the following periods: antepartum, postpartum, oral contraceptive use, surgery, immobilization, cast, and malignancy
• Mechanical heart valve
• Legal lower age limitations (country specific)
• Prior participation in TIPPS
• Unable/unwilling to provide informed consent

Where it is running

• Saint Louis University — St Louis, Missouri, United States
• University of Utah Health Sciences Centre — Salt Lake City, Utah, United States
• Royal Alexandra Hospital — Edmonton, Alberta, Canada
• QEII Health Sciences Centre — Halifax, Nova Scotia, Canada
• Hamilton Health Sciences Centre — Hamilton, Ontario, Canada
• The Ottawa Hospital, Civic Campus — Ottawa, Ontario, Canada
• Mount Sinai Hospital — Toronto, Ontario, Canada
• Women's College Health Sciences Centre — Toronto, Ontario, Canada
• SMBD Jewish General Hospital — Montreal, Quebec, Canada
• St Mary's Hospital Centre — Montreal, Quebec, Canada
• CHA, Hopital Enfant Jesus — Québec, Quebec, Canada
• Royal University Hospital — Saskatoon, Saskatchewan, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.